Why I Voted 'No' on the New ALS Drug

(MedPage Today) -- In March and September 2022, I served on an FDA Advisory Committee reviewing the application of Amylyx Pharmaceuticals for the novel drug AMX0035 for patients with amyotrophic lateral sclerosis (ALS). I voted against approval...
Source: MedPage Today Public Health - Category: American Health Source Type: news